F Seker1, J Hesser2, M A Brockmann3, E Neumaier-Probst4, C Groden4, R Schubert5, C Brockmann6. 1. Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany. 2. Experimental Radiation Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. 3. Clinic for Diagnostic and Interventional Neuroradiology, University Hospital of the RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany. 4. Department of Neuroradiology, University Medical Center Mannheim, Mannheim, Germany. 5. Research Division Cardiovascular Physiology, Centre for Biomedicine and Medical Technology Mannheim (CBTM), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. 6. Clinic for Diagnostic and Interventional Neuroradiology, University Hospital of the RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany. caro.brockmann@gmx.de.
Abstract
PURPOSE: Intra-arterial (IA) administration of nimodipine has been shown to be an effective treatment for subarachnoid hemorrhage-related cerebral vasospasm. The concentrations achieved in cerebral arteries during this procedure, though, are unknown. Therefore, there are no clinical studies investigating dose-dependent effects of nimodipine. We aimed at providing a pharmacokinetic model for IA nimodipine therapy for this purpose. METHODS: A two-compartment pharmacokinetic model for intravenous nimodipine therapy was modified and used to assess cerebral arterial nimodipine concentration during IA nimodipine infusion into the internal carotid artery (ICA). RESULTS: According to our simulations, continuous IA nimodipine infusion at 2 mg/h and 1 mg/h resulted in steady-state cerebral arterial concentrations of about 200 ng/ml and 100 ng/ml assuming an ICA blood flow of 200 ml/min and a clearance of 70 l/h. About 85 % of the maximal concentration is achieved within the first minute of IA infusion independent on the infusion dose. Within the range of physiological and pharmacokinetic data available in the literature, ICA blood flow has more impact on cerebral arterial concentration than nimodipine clearance. CONCLUSION: The presented pharmacokinetic model is suitable for estimations of cerebral arterial nimodipine concentration during IA infusion. It may, for instance, assist in dose-dependent analyses of angiographic results.
PURPOSE: Intra-arterial (IA) administration of nimodipine has been shown to be an effective treatment for subarachnoid hemorrhage-related cerebral vasospasm. The concentrations achieved in cerebral arteries during this procedure, though, are unknown. Therefore, there are no clinical studies investigating dose-dependent effects of nimodipine. We aimed at providing a pharmacokinetic model for IA nimodipine therapy for this purpose. METHODS: A two-compartment pharmacokinetic model for intravenous nimodipine therapy was modified and used to assess cerebral arterial nimodipine concentration during IA nimodipine infusion into the internal carotid artery (ICA). RESULTS: According to our simulations, continuous IA nimodipine infusion at 2 mg/h and 1 mg/h resulted in steady-state cerebral arterial concentrations of about 200 ng/ml and 100 ng/ml assuming an ICA blood flow of 200 ml/min and a clearance of 70 l/h. About 85 % of the maximal concentration is achieved within the first minute of IA infusion independent on the infusion dose. Within the range of physiological and pharmacokinetic data available in the literature, ICA blood flow has more impact on cerebral arterial concentration than nimodipine clearance. CONCLUSION: The presented pharmacokinetic model is suitable for estimations of cerebral arterial nimodipine concentration during IA infusion. It may, for instance, assist in dose-dependent analyses of angiographic results.
Authors: M Murat Firat; Veli Gelebek; Hakan S Orer; Deniz Belen; Ahmet K Firat; Ferhun Balkanci Journal: AJNR Am J Neuroradiol Date: 2005 Jun-Jul Impact factor: 3.825
Authors: W-S Cho; H-S Kang; J E Kim; O-K Kwon; C W Oh; Y J Son; B J Know; C Jung; M H Hang Journal: Interv Neuroradiol Date: 2011-06-20 Impact factor: 1.610
Authors: Fatih Seker; Jürgen Hesser; Eva Neumaier-Probst; Christoph Groden; Marc A Brockmann; Rudolf Schubert; Carolin Brockmann Journal: Neuroradiology Date: 2012-08-05 Impact factor: 2.804
Authors: Miriam Weiss; Walid Albanna; Catharina Conzen-Dilger; Nick Kastenholz; Katharina Seyfried; Hani Ridwan; Martin Wiesmann; Michael Veldeman; Tobias Philip Schmidt; Murad Megjhani; Henna Schulze-Steinen; Hans Clusmann; Marinus Johannes Hermanus Aries; Soojin Park; Gerrit Alexander Schubert Journal: Stroke Date: 2022-06-08 Impact factor: 10.170
Authors: Miriam Weiss; Catharina Conzen; Marguerite Mueller; Martin Wiesmann; Hans Clusmann; Walid Albanna; Gerrit Alexander Schubert Journal: Front Neurol Date: 2019-02-21 Impact factor: 4.003
Authors: Andreas Kramer; Moritz Selbach; Thomas Kerz; Axel Neulen; Marc A Brockmann; Florian Ringel; Carolin Brockmann Journal: Front Neurol Date: 2022-03-15 Impact factor: 4.003
Authors: Axel Neulen; Svenja Kunzelmann; Michael Kosterhon; Tobias Pantel; Maximilian Stein; Manfred Berres; Florian Ringel; Marc A Brockmann; Carolin Brockmann; Sven R Kantelhardt Journal: Front Neurol Date: 2020-01-30 Impact factor: 4.003